Etiology and basis of secondary dyslipidemia and related abnormalities in lipid metabolism are known conditions such as diabetes mellitus, hyper and hypothyroidism, cirrhosis, alcoholism and deficiency of some micro nutrients such as Vitamins. It has been reported that Vitamin B12 supplementation in metabolically compromised individuals helps in reduction of insulin resistance, obesity and normalcy of dyslipidemic state. In this study, we investigated protective role of Vitamin B12 supplementation in individuals with Diabetes mellitus co-morbid with hypertryglycerdemia, hypercholstreima and lipoprotein abnormalities. Thirty four (n = 34) individuals which were confirmed cases of Diabetes mellitus, suffering various forms of dyslipidemia, were selected via clinical and laboratory investigation scrutiny. Subjects were advised Vitamin B12 supplementation, one (2.4 mg) Oral Dose/day for 3 months or more by attending physicians. Blood analysis of patients was performed before start of Vitamin B12 supplementation, and at the end of 90th day of treatment for HbA1c, Cholesterol, triglycerides, HDL, LDL and Vitamin B12 by standardized methods. Data exhibited marked significant (P< 0.00001) changes between biochemical parameters of zero day and after 90 day in all parameters suggesting protective and facilitating efficacy of Vitamin B12 supplementation.